Acelyrin Inc (SLRN) Annual Balance Sheets

Annual · GAAP · USD millions
Access SLRN quarterly Balance Sheets →
Balance sheet data covering Acelyrin Inc– offers a view into how Dec 31 2024's financial position has changed alongside business activity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Dec 31 2023)
Assets
Cash & cash equivalent73.89
Cash & Short-term Investments73.00
Other Current Assets373.99
Prepaid Expense And Other Assets Current33.11
Total Current Assets480.99
Equipment/Property/Plant Net1.64
Other Assets, Noncurrent8.52
Debt Securities Available For Sale Excluding Accrued Interest Current373.99
Prepaid Expense And Other Assets Noncurrent1.22
Operating Lease Right Of Use Asset6.75
Total Assets491.14
Liabilities
Accounts Payable, Current AC4.89
Other Liabilities, Current21.69
Total Current Liabilities26.58
Total Long-term Debt0.00
Other liabilities, Noncurrent6.27
OperatingLeaseLiabilityNoncurrent6.27
Accrued Research And Development Expense Current11.04
Accrued Compensation And Other Current Liabilities9.30
Severance Liability Current1.35
Total Liabilities32.85
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,195.24
Retained Earnings / Accumulated Deficit-736.95
Other Equity-0.01
Common Stockholder's Equity458.29
Total Stockholder's Equity458.29
Liabilities & Stockholder's Equity491.14
4 historic quarters locked

Sign in to unlock the full Acelyrin Inc balance sheet history.

About Acelyrin Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001962918-25-000022

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.